Neoplasms, Pancreatic Terminated Phase 2 Trials for Sunitinib (DB01268)

Also known as: Pancreatic Neoplasm / Pancreatic Neoplasms / Tumor of pancreas / Pancreas neoplasm NOS / Pancreatic neoplasm NOS

IndicationStatusPhase
DBCOND0054129 (Neoplasms, Pancreatic)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01215578Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTreatment